Neovascular age‐related macular degeneration: A review of findings from the real‐world Fight Retinal Blindness! registry

The use of vascular endothelial growth factor (VEGF) inhibitors has revolutionised the treatment of neovascular age‐related macular degeneration (nAMD) since the pivotal Phase III studies demonstrated their efficacy more than 10 years ago. The Fight Retinal Blindness! project was developed to track...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Vuong, Barthelmes, Daniel, Gillies, Mark C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518964/
https://www.ncbi.nlm.nih.gov/pubmed/34013534
http://dx.doi.org/10.1111/ceo.13949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518964/
https://www.ncbi.nlm.nih.gov/pubmed/34013534
http://dx.doi.org/10.1111/ceo.13949

Ejemplares similares